Literature DB >> 31321444

ZNFX1 anti-sense RNA 1 promotes the tumorigenesis of prostate cancer by regulating c-Myc expression via a regulatory network of competing endogenous RNAs.

Xiaolu Cui1, Chiyuan Piao1, Chengcheng Lv2, Xuyong Lin3, Zhe Zhang1, Xiankui Liu4.   

Abstract

ZNFX1 anti-sense RNA 1 (ZFAS1) has been indicated in the tumorigenesis of various human cancers. However, the role of ZFAS1 in prostate cancer (PCa) progression and the underlying mechanisms remain incompletely understood. In the present study, we discovered that ZFAS1 is upregulated in PCa and that ZFAS1 overexpression predicted poor clinical outcomes. ZFAS1 overexpression notably promoted the proliferation, invasion, and epithelial-mesenchymal transition of PCa cells. Furthermore, we not only discovered that miR-27a/15a/16 are targeted by ZFAS1, which binds to their miRNA-response elements, but also revealed their tumor suppressor roles in PCa. We also identified that the Hippo pathway transducer YAP1, as well as its cooperator, TEAD1, are common downstream targets of miR-27a/15a/16. In addition, H3K9 demethylase KDM3A was found to be another target gene of miR-27a. Importantly, YAP1, TEAD1, and KDM3A all act as strong c-Myc inducers in an androgen-independent manner. Taken together, we suggest a regulatory network in which ZFAS1 is capable of enhancing c-Myc expression by inducing the expression of YAP1, TEAD1, and KDM3A through crosstalk with their upstream miRNAs, thereby globally promoting prostate cancer tumorigenesis.

Entities:  

Keywords:  Competing endogenous RNAs; Prostate cancer; ZNFX1 anti-sense RNA 1; c-Myc

Mesh:

Substances:

Year:  2019        PMID: 31321444     DOI: 10.1007/s00018-019-03226-x

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  65 in total

1.  Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs.

Authors:  Yvonne Tay; Lev Kats; Leonardo Salmena; Dror Weiss; Shen Mynn Tan; Ugo Ala; Florian Karreth; Laura Poliseno; Paolo Provero; Ferdinando Di Cunto; Judy Lieberman; Isidore Rigoutsos; Pier Paolo Pandolfi
Journal:  Cell       Date:  2011-10-14       Impact factor: 41.582

2.  SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer.

Authors:  Marjan E Askarian-Amiri; Joanna Crawford; Juliet D French; Chanel E Smart; Martin A Smith; Michael B Clark; Kelin Ru; Tim R Mercer; Ella R Thompson; Sunil R Lakhani; Ana C Vargas; Ian G Campbell; Melissa A Brown; Marcel E Dinger; John S Mattick
Journal:  RNA       Date:  2011-04-01       Impact factor: 4.942

Review 3.  The emerging roles of YAP and TAZ in cancer.

Authors:  Toshiro Moroishi; Carsten Gram Hansen; Kun-Liang Guan
Journal:  Nat Rev Cancer       Date:  2015-01-16       Impact factor: 60.716

4.  The BRAF pseudogene functions as a competitive endogenous RNA and induces lymphoma in vivo.

Authors:  Florian A Karreth; Markus Reschke; Anna Ruocco; Christopher Ng; Bjoern Chapuy; Valentine Léopold; Marcela Sjoberg; Thomas M Keane; Akanksha Verma; Ugo Ala; Yvonne Tay; David Wu; Nina Seitzer; Martin Del Castillo Velasco-Herrera; Anne Bothmer; Jacqueline Fung; Fernanda Langellotto; Scott J Rodig; Olivier Elemento; Margaret A Shipp; David J Adams; Roberto Chiarle; Pier Paolo Pandolfi
Journal:  Cell       Date:  2015-04-02       Impact factor: 41.582

5.  A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer.

Authors:  Shi Jiao; Huizhen Wang; Zhubing Shi; Aimei Dong; Wenjing Zhang; Xiaomin Song; Feng He; Yicui Wang; Zhenzhen Zhang; Wenjia Wang; Xin Wang; Tong Guo; Peixue Li; Yun Zhao; Hongbin Ji; Lei Zhang; Zhaocai Zhou
Journal:  Cancer Cell       Date:  2014-02-10       Impact factor: 31.743

6.  Control of histone H3 lysine 9 (H3K9) methylation state via cooperative two-step demethylation by Jumonji domain containing 1A (JMJD1A) homodimer.

Authors:  Satoshi Goda; Takayuki Isagawa; Yoko Chikaoka; Takeshi Kawamura; Hiroyuki Aburatani
Journal:  J Biol Chem       Date:  2013-11-08       Impact factor: 5.157

7.  Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility.

Authors:  Zhongyuan Wang; Yanping Wu; Haifeng Wang; Yangqing Zhang; Lin Mei; Xuexun Fang; Xudong Zhang; Fang Zhang; Hongbo Chen; Ying Liu; Yuyang Jiang; Shengnan Sun; Yi Zheng; Na Li; Laiqiang Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-23       Impact factor: 11.205

8.  c-Myc-mediated repression of miR-15-16 in hypoxia is induced by increased HIF-2α and promotes tumor angiogenesis and metastasis by upregulating FGF2.

Authors:  G Xue; H-L Yan; Y Zhang; L-Q Hao; X-T Zhu; Q Mei; S-H Sun
Journal:  Oncogene       Date:  2014-04-07       Impact factor: 9.867

9.  The miR-27a-calreticulin axis affects drug-induced immunogenic cell death in human colorectal cancer cells.

Authors:  T Colangelo; G Polcaro; P Ziccardi; L Muccillo; M Galgani; B Pucci; M Rita Milone; A Budillon; M Santopaolo; G Mazzoccoli; G Matarese; L Sabatino; V Colantuoni
Journal:  Cell Death Dis       Date:  2016-02-25       Impact factor: 8.469

10.  Hypoxic exosomes facilitate bladder tumor growth and development through transferring long non-coding RNA-UCA1.

Authors:  Mei Xue; Wei Chen; An Xiang; Ruiqi Wang; He Chen; Jingjing Pan; Huan Pang; Hongli An; Xiang Wang; Huilian Hou; Xu Li
Journal:  Mol Cancer       Date:  2017-08-25       Impact factor: 27.401

View more
  10 in total

1.  Astragalus mongholicus Bunge-Curcuma aromatica Salisb. suppresses growth and metastasis of colorectal cancer cells by inhibiting M2 macrophage polarization via a Sp1/ZFAS1/miR-153-3p/CCR5 regulatory axis.

Authors:  Junfei Gu; Ruolan Sun; Decai Tang; Fuyan Liu; Xiangwei Chang; Qiaohan Wang
Journal:  Cell Biol Toxicol       Date:  2022-01-24       Impact factor: 6.819

2.  IncRNA ZFAS1 contributes to the radioresistance of nasopharyngeal carcinoma cells by sponging hsa-miR-7-5p to upregulate ENO2.

Authors:  Jiaojiao Peng; Feng Liu; Hong Zheng; Qi Wu; Shixi Liu
Journal:  Cell Cycle       Date:  2020-12-20       Impact factor: 4.534

3.  Downregulation of miR-335 exhibited an oncogenic effect via promoting KDM3A/YAP1 networks in clear cell renal cell carcinoma.

Authors:  Wenqiang Zhang; Ruiyu Liu; Lin Zhang; Chao Wang; Ziyan Dong; Jiasheng Feng; Mayao Luo; Yifan Zhang; Zhuofan Xu; Shidong Lv; Qiang Wei
Journal:  Cancer Gene Ther       Date:  2021-04-23       Impact factor: 5.854

4.  lncRNA ZFAS1 Is Involved in the Proliferation, Invasion and Metastasis of Prostate Cancer Cells Through Competitively Binding to miR-135a-5p.

Authors:  Jiaqiang Pan; Xingyan Xu; Guangliang Wang
Journal:  Cancer Manag Res       Date:  2020-02-13       Impact factor: 3.989

Review 5.  Advances in Histone Demethylase KDM3A as a Cancer Therapeutic Target.

Authors:  Jung Yoo; Yu Hyun Jeon; Ha Young Cho; Sang Wu Lee; Go Woon Kim; Dong Hoon Lee; So Hee Kwon
Journal:  Cancers (Basel)       Date:  2020-04-28       Impact factor: 6.639

Review 6.  Targeting the Hippo Pathway in Prostate Cancer: What's New?

Authors:  Kelly Coffey
Journal:  Cancers (Basel)       Date:  2021-02-04       Impact factor: 6.575

7.  Integrative Analysis and Experimental Validation Indicated That SNHG17 Is a Prognostic Marker in Prostate Cancer and a Modulator of the Tumor Microenvironment via a Competitive Endogenous RNA Regulatory Network.

Authors:  Jinling Li; Hongyuan Yu; Jinlong Yao; Zhenming Jiang; Zhenhua Li; Xiaolu Cui
Journal:  Oxid Med Cell Longev       Date:  2022-07-12       Impact factor: 7.310

8.  LncRNA MNX1-AS1 promotes progression of intrahepatic cholangiocarcinoma through the MNX1/Hippo axis.

Authors:  Fengwei Li; Qinjunjie Chen; Hui Xue; Lei Zhang; Kui Wang; Feng Shen
Journal:  Cell Death Dis       Date:  2020-10-22       Impact factor: 8.469

Review 9.  The crosstalk between lncRNAs and the Hippo signalling pathway in cancer progression.

Authors:  Chao Tu; Kexin Yang; Lu Wan; Jieyu He; Lin Qi; Wanchun Wang; Qiong Lu; Zhihong Li
Journal:  Cell Prolif       Date:  2020-08-10       Impact factor: 6.831

Review 10.  Regulation of Neuroendocrine-like Differentiation in Prostate Cancer by Non-Coding RNAs.

Authors:  Eva Slabáková; Zuzana Kahounová; Jiřina Procházková; Karel Souček
Journal:  Noncoding RNA       Date:  2021-12-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.